Literature DB >> 31858993

Disruptive anti-IgE inhibitors prevent mast cell-dependent early airway response in viable atopic lung tissue.

Sharon Jiménez Delgado1, Susann Dehmel1, Elaine Twisterling2, Judy Wichmann2, Danny Jonigk3, Gregor Warnecke3, Peter Braubach3, Hans-Gerd Fieguth4, Ludwig Wilkens4, Franziska Dahlmann1, Franz-Josef Kaup5, Alexander Eggel6, Sascha Knauf5, Katherina Sewald7, Armin Braun1.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31858993     DOI： 10.1016/j.jaci.2019.11.002

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  3 in total

Review 1.  Past, present, and future of anti-IgE biologics.

Authors:  Pascal Guntern; Alexander Eggel
Journal:  Allergy       Date:  2020-04-21       Impact factor: 13.146

2.  A modified protocol for successful miRNA profiling in human precision-cut lung slices (PCLS).

Authors:  Monika Niehof; Stella Marie Reamon-Buettner; Olga Danov; Tanja Hansen; Katherina Sewald
Journal:  BMC Res Notes       Date:  2021-07-02

Review 3.  Regulation of Trafficking and Signaling of the High Affinity IgE Receptor by FcεRIβ and the Potential Impact of FcεRIβ Splicing in Allergic Inflammation.

Authors:  Greer K Arthur; Glenn Cruse
Journal:  Int J Mol Sci       Date:  2022-01-12       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.